Child-Pugh评分、MELD评分、MELD-Na评分、APASAL评分和R评分对肝硬化伴食管胃静脉曲张再出血及死亡的预测价值

马佳丽; 陈旭; 何玲玲; 魏红山; 李坪

doi:10.3969/j.issn.1001-5256.2020.06.018

Child-Pugh评分、MELD评分、MELD-Na评分、APASAL评分和R评分对肝硬化伴食管胃静脉曲张再出血及死亡的预测价值

DOI: 10.3969/j.issn.1001-5256.2020.06.018

首都医科大学附属北京地坛医院消化内科

基金项目:

首都医科大学附属北京地坛医院青年人才发展基金“萌芽”支持计划项目(DTMY201807)；首都临床特色应用研究(Z181100001718084)；北京市医院管理中心消化内科学科协同发展中心专项(XXZ04)；

详细信息

中图分类号: R575.2
计量
- 文章访问数: 1894
- HTML全文浏览量: 89
- PDF下载量: 273
- 被引次数: 2
出版历程
- 出版日期: 2020-06-20

Value of Child-Pugh score,Model for End-Stage Liver Disease score,MELD combined with serum sodium concentration,APASAL score,and R-score in predicting rebleeding and death in cirrhotic patients with esophagogastric variceal bleeding

Research funding:

摘要

摘要:
目的验证Child-Pugh评分、MELD评分、MELD-Na评分、APASAL评分和R评分5种风险评分系统对肝硬化伴食管胃静脉曲张出血患者再出血及死亡的诊断价值。方法选取2013年1月-2016年1月因肝硬化伴食管胃静脉曲张破裂出血于首都医科大学附属北京地坛医院行内镜下治疗,并为出血首次行内镜治疗且随访时间超过3年的患者。观察指标包括年龄、性别、体质量、血压、血常规、肝肾功能、凝血、腹部超声等影像学指标及肝性脑病、腹水、感染等并发症发生情况。以静脉曲张再出血为主要研究终点,以死亡为次要研究终点。计量资料两组间比较采用t检验或Wilcoxon秩和检验;计数资料两组间比较采用χ2检验。相关性分析采用Spearman相关分析。采用受试者工作特征曲线（ROC曲线）评价5种风险评分系统对患者再出血及死亡的诊断价值。结果共纳入305例患者,其中53例（17. 38%）患者在随访过程中出现了静脉曲张再出血。再出血组与无再出血组患者比较,年龄、ALT、DBil、国际化标准比值、门静脉内径、MELD评分、MELD-Na评分及R评分差异均有统计学意义（P值均<0. 05）。相...
- 肝硬化 /
- 食管和胃静脉曲张 /
- 出血 /
- 死亡
Abstract:
Objective To investigate the value of Child-Pugh score,Model for End-Stage Liver Disease( MELD) score,MELD combined with serum sodium concentration( MELD-Na score),APASAL score,and R-score in predicting rebleeding and death in cirrhotic patients with esophagogastric variceal bleeding. Methods The patients with liver cirrhosis and gastroesophageal variceal bleeding who underwent endoscopic therapy for bleeding for the first time in Beijing Ditan Hospital,Capital Medical University,from January 2013 to January 2016 and were followed up for more than 3 years were enrolled. Observation indices included age,sex,body weight,blood pressure,routine blood test results,hepatic and renal function,coagulation,radiological examination( including abdominal ultrasound),and complications( including hepatic encephalopathy,ascites,and infection). Variceal rebleeding was the primary endpoint,and death was the secondary endpoint. The t-test or the Wilcoxon rank-sum test was used for comparison of continuous data between two groups,and the chi-square test was used for comparison of categorical data between two groups. A Spearman correlation analysis was performed,and the receiver operating characteristic( ROC) curve was used to investigate the value of these five risk scoring systems in the diagnosis of rebleeding and death. Results A total of 305 patients were enrolled,among whom 53( 17. 38%) experienced variceal rebleeding during follow-up. There were significant differences between the rebleeding group and the non-rebleeding group in age,alanine aminotransferase,direct bilirubin,international normalized ratio,diameter of the portal vein,MELD score,MELD-Na score,and R-score( all P < 0. 05). The correlation analysis showed a significant correlation between any two scores except between APASAL score and MELD score/R-score and between MELD-Na score and R-score( all P < 0. 05). The ROC curve analysis showed that MELD score,MELD-Na score,and R-score had a certain value in predicting rebleeding,with an area under the ROC curve( AUC) of 0. 645( 95% confidence interval [CI]: 0. 563-0. 727,P = 0. 001),0. 637( 95% CI: 0. 552-0. 723,P = 0. 002),and 0. 647( 95% CI: 0. 565-0. 729,P = 0. 001),respectively,and Child-Pugh score had a certain diagnostic value for death,with an AUC of 0. 610( 95% CI: 0. 541-0. 680,P = 0. 002). Conclusion Child-Pugh score,MELD score,MELD-Na score,APASAL score,and R-score have a limited value in predicting variceal rebleeding,and only Child-Pugh score has a certain diagnostic value for death.
- liver cirrhosis /
- esophageal and gastric varices /
- hemorrhage /
- death

HTML全文

参考文献(29)

[1] KRIGE JE,SHAW JM,BORNMAN PC. The evolving role of endoscopic treatment for bleeding esophageal varices[J].World J Surg,2005,29(8):966-973.

[2] D'AMICO G,PASTA L,MORABITO A,et al. Competing risks and prognostic stages of cirrhosis:A 25-year inception cohort study of 494 patients[J]. Aliment Pharmacol Ther,2014,39(10):1180-1193.

[3] MERLI M,NICOLINI G,ANGELONI S,et al. Incidence and natural history of small esophageal varices in cirrhotic patients[J]. J Hepatol,2003,38(3):266-272.

[4] North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study[J]. N Engl J Med,1988,319(15):983-989.

[5] HAQ I,TRIPATHI D. Recent advances in the management of variceal bleeding[J]. Gastroenterol Rep(Oxf),2017,5(2):113-126.

[6] KIM YD. Management of acute variceal bleeding[J]. Clin Endosc,2014,47(4):308-314.

[7] IBRAHIM M,MOSTAFA I,DEVIRE J. New developments in managing variceal bleeding[J]. Gastroenterology,2018,154(7):1964-1969.

[8] BOSCH J,GARCA-PAGN JC. Prevention of variceal rebleeding[J]. Lancet,2003,361(9361):952-954.

[9] TSOCHATZIS EA,BOSCH J,BURROUGHS AK. Liver cirrhosis[J]. Lancet,2014,383(9930):1749-1761.

[10] Chinese Society of Hepatology,Chinese Medical Association;Chinese Society of Gastroenterology,Chinese Medical Association; Chinese Society of Endoscopy,Chinese Medical Association. Guidelines for the diagnosis and treatment of esophageal and gastric variceal bleeding in cirrhotic portal hypertension[J]. J Clin Hepatol,2016,32(2):203-219.(in Chinese)中华医学会肝病学分会，中华医学会消化病学分会，中华医学会内镜学分会．肝硬化门静脉高压食管胃静脉曲张出血的防治指南[J]．临床肝胆病杂志，2016,32(2):203-219.

[11] MALINCHOC M,KAMATH PS,GORDON FD,et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts[J]. Hepatology,2000,31(4):864-871.

[12] CHEN WT,LIN CY,SHEEN IS,et al. MELD score can predict early mortality in patients with rebleeding after band ligation for variceal bleeding[J]. World J Gastroenterol,2011,17(16):2120-2125.

[13] WANG J,WANG AJ,LI BM,et al. MELD-Na:Effective in predicting rebleeding in cirrhosis after cessation of esophageal variceal hemorrhage by endoscopic therapy[J]. J Clin Gastroenterol,2014,48(10):870-877.

[14] ORLOFF MJ,VAIDA F,ISENBERG JI,et al. Child-Turcotte score versus MELD for prognosis in a randomized controlled trial of emergency treatment of bleeding esophageal varices in cirrhosis[J]. J Surg Res,2012,178(1):139-146.

[15] ROCKALL TA,LOGAN RF,DEVLIN HB,et al. Risk assessment after acute upper gastrointestinal haemorrhage[J]. Gut,1996,38(3):316-321.

[16] SRIRAJASKANTHAN R,CONN R,BULWER C,et al. The Glasgow Blatchford scoring system enables accurate risk stratification of patients with upper gastrointestinal haemorrhage[J]. Int J Clin Pract,2010,64(7):868-874.

[17] CHENG DW,LU YW,TELLER T,et al. A modified Glasgow Blatchford Score improves risk stratification in upper gastrointestinal bleed:A prospective comparison of scoring systems[J]. Aliment Pharmacol Ther,2012,36(8):782-789.

[18] Digestive Endoscopy Group of Endoscopists Committee of Chinese Medical Doctor Association. Guidenlines for the diagnosis and treatment of acute non-variceal upper gastrointestinal bleeding(2018,Hangzhou)[J]. Natl Med J China,2019,99(8):571-578.(in Chinese)中国医师协会内镜医师分会消化内镜专业委员会．急性非静脉曲张性上消化道出血诊治指南(2018年，杭州)[J]．中华医学杂志，2019,99(8):571-578.

[19] SARIN SK,KUMAR A,ANGUS PW,et al. Diagnosis and management of acute variceal bleeding:Asian Pacific Association for Study of the Liver recommendations[J]. Hepatol Int,2011,5(2):607-624.

[20] GRAHAM DY,SMITH JL. The course of patients after variceal hemorrhage[J]. Gastroenterology,1981,80(4):800-809.

[21] JAIRATH V,REHAL S,LOGAN R,et al. Acute variceal haemorrhage in the United Kingdom:Patient characteristics,management and outcomes in a nationwide audit[J]. Dig Liver Dis,2014,46(5):419-426.

[22] HE L,LI P,JIANG Y,et al. A new algorithm for predicting long-term survival in chronic hepatitis B patients with variceal bleeding after endoscopic therapy[J]. Dig Liver Dis,2019,51(8):1166-1171.

[23] BELL H,JAHNSEN J,KITTANG E,et al. Long-term prognosis of patients with alcoholic liver cirrhosis:A 15-year followup study of 100 Norwegian patients admitted to one unit[J].Scand J Gastroenterol,2004,39(9):858-863.

[24] JEPSEN P,OTT P,ANDERSEN PK,et al. Clinical course of alcoholic liver cirrhosis:A Danish population-based cohort study[J]. Hepatology,2010,51(5):1675-1682.

[25] PARK DK,UM SH,LEE JW,et al. Clinical significance of variceal hemorrhage in recent years in patients with liver cirrhosis and esophageal varices[J]. J Gastroenterol Hepatol,2004,19(9):1042-1051.

[26] CHO H,NAGATA N,SHIMBO T,et al. Recurrence and prognosis of patients emergently hospitalized for acute esophageal variceal bleeding:A long-term cohort study[J]. Hepatol Res,2016,46(13):1338-1346.

[27] GARCIA-TSAO G,ABRALDES JG,BERZIGOTTI A,et al.Portal hypertensive bleeding in cirrhosis:Risk stratification,diagnosis,and management:2016 practice guidance by the American Association for the study of liver diseases[J]. Hepatology,2017,65(1):310-335.

[28] HOLSTER IL,TJWA ET,MOELKER A,et al. Covered transjugular intrahepatic portosystemic shunt versus endoscopic therapy+β-blocker for prevention of variceal rebleeding[J].Hepatology,2016,63(2):581-589.

[29] AMITRANO L,GUARDASCIONE MA,BENNATO R,et al.MELD score and hepatocellular carcinoma identify patients at different risk of short-term mortality among cirrhotics bleeding from esophageal varices[J]. J Hepatol,2005,42(6):820-825.

施引文献

期刊类型引用(2)

1.	韦明婵，林江，张婷，秦祖杰，李凯风，袁小玲，黄汉儒. 基于网络药理学和分子对接探讨田基黄-虎杖治疗肝癌作用机制. 中国中医药图书情报杂志. 2025(02): 44-50 . 百度学术
2.	李晓斌，刘博文，马贵萍，李峰，胡世平. 基于“态靶理论”探讨中医药调节肠道菌群干预肝细胞癌的内涵. 中西医结合肝病杂志. 2024(09): 826-829 . 百度学术